HEALTHCAP VIII, L.P. purchased 14.0% of their position (250K shares) of SPRUCE BIOSCIENCES, INC. on the open market
Open‑market purchase worth $3.75M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/16/2020ACC: 0001209191-20-055012
10% Owner
Since Oct 2020
-9.63M
Net shares
Net seller
$3.75M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
2.03M acquired · 11.67M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.78M
Price / share
—
Trade value
—
% of position
New position
10/14/2020
0.00→1.78M
Common Stock
Direct
Shares
+250K
Price / share
$15.00
Trade value
$3.75M
% of position
14.0%
10/14/2020
1.78M→2.03M
Total
Net shares
+2.03M
Net value
$3.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/14/2020 | C · Conversion | +1.78M | — | — | New position | 0.00 | 1.78M |
| Common Stock Direct | 10/14/2020 | P · Purchase | +250K | $15.00 | $3.75M | 14.0% | 1.78M | 2.03M |
| Total | +2.03M | $3.75M | ||||||
Derivative Transactions1
Series B Preferred Stock
Direct
Converts to
Common Stock
1.78M shares
Shares
−11.67M
Strike price
Held after
0.00
Exercisable
—
10/14/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock1.78M shares | 10/14/2020 | C · Conversion | −11.67M | — | 0.00 |